Nicergoline

Varson Capsulas

5 mg cápsula duraSpainMarketedAuthorised 31 Mar 1976

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Nicergoline

Varson Capsulas

5 mg cápsula duraSpainMarketedAuthorised 31 Mar 1976

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sermion 10MG TabSaudi Arabia · Pfizer

Sermion Tab 5MGSaudi Arabia · Pfizer

Sermion Tablets 10MGTaiwan · 糖衣錠 · 暉致醫藥股份有限公司

Bolinon S.C. Tablets 10MG (Nicergoline) "K.D."Taiwan · 糖衣錠 · 可達藥品有限公司

Ceramon S.C. Tablets 10MG (Nicergoline) "DCPC"Taiwan · 糖衣錠 · 仁興化學製藥股份有限公司

Packs

Pack	Code	Status
VARSON CAPSULAS, 45 cápsulas	844738

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Nicergoline
Strength: 5 mg
Dosage form: cápsula dura
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 31 Mar 1976
Registration: 53366
Marketing authorisation holder: Laboratorios Almirall S.L.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica